AbbVie Inc (ABBV)
Solvency ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Financial leverage ratio | 13.00 | 11.26 | 10.52 | 10.14 | 8.04 | 8.84 | 9.77 | 8.80 | 9.51 | 10.99 | 11.77 | 10.98 | 11.51 | 9.80 | 10.17 | — | — | — | — | — |
The solvency ratios for Abbvie Inc show a consistent trend over the past eight quarters. The Debt-to-assets ratio has remained relatively stable around 0.45 to 0.46, indicating that approximately 45-46% of the company's assets are financed through debt.
The Debt-to-capital ratio has also exhibited stability, hovering between 0.82 to 0.85. This suggests that debt accounts for around 82-85% of Abbvie's capital structure.
The Debt-to-equity ratio has shown a slight increase from Q1 2022 to Q4 2022, peaking at 5.73 before gradually decreasing to 4.68 in Q1 2023. This ratio indicates the proportion of debt to equity in the company's capital structure, with higher values indicating higher financial leverage.
The Financial leverage ratio has followed a similar pattern, starting at 8.80 in Q1 2022, increasing to 13.00 in Q4 2023. This ratio reflects the extent to which Abbvie is using debt to fund its operations and investments.
Overall, Abbvie Inc's solvency ratios demonstrate a stable but leveraged financial structure, with debt playing a significant role in financing the company's operations. Investors and stakeholders may want to monitor these ratios to assess the company's ability to meet its financial obligations and manage its debt levels effectively.
Coverage ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 3.81 | 4.59 | 5.68 | 5.03 | 7.04 | 7.58 | 7.17 | 7.00 | 6.36 | 3.91 | 3.40 | 2.65 | 2.38 | 4.35 | 4.35 | 5.58 | 5.72 | 2.86 | 3.55 | 4.47 |
Interest coverage ratio measures a company's ability to meet its interest payments on debt obligations. Abbvie Inc's interest coverage ratio has been relatively stable and healthy over the past eight quarters, ranging from 7.93 to 9.65. This indicates that Abbvie has consistently generated sufficient operating income to cover its interest expenses, providing a buffer against potential financial difficulties. The trend in interest coverage suggests that the company has maintained a strong financial position and has been effectively managing its debt obligations.